TP53 and neoplasm: This discovery not only expands the theoretical framework of p53 functional polymorphism in DNA damage response, but also indicates that the co‐evolution of inflammation and proliferation in the tumour microenvironment may be a key therapeutic point for regulating chemotherapy sensitivity.